Choosing and successfully sustaining competitive strategies in the European pharmaceutical industry:
Gespeichert in:
1. Verfasser: | |
---|---|
Format: | Buch |
Sprache: | English |
Veröffentlicht: |
Köln
MPIFG
2008
|
Schriftenreihe: | MPIFG discussion paper
2008,9 |
Schlagworte: | |
Beschreibung: | Literaturverz. S. 26 - 28 |
Beschreibung: | 31 S. 30 cm |
Internformat
MARC
LEADER | 00000nam a2200000zcb4500 | ||
---|---|---|---|
001 | BV023563622 | ||
003 | DE-604 | ||
005 | 20081104000000.0 | ||
007 | t| | ||
008 | 081021s2008 gw |||| 00||| eng d | ||
016 | 7 | |a 99070419X |2 DE-101 | |
020 | |c geh. | ||
035 | |a (OCoLC)277046457 | ||
035 | |a (DE-599)DNB99070419X | ||
040 | |a DE-604 |b ger | ||
041 | 0 | |a eng | |
044 | |a gw |c XA-DE | ||
049 | |a DE-521 |a DE-188 | ||
084 | |a QR 525 |0 (DE-625)142044: |2 rvk | ||
084 | |a 330 |2 sdnb | ||
100 | 1 | |a Herrmann, Andrea M. |e Verfasser |4 aut | |
245 | 1 | 0 | |a Choosing and successfully sustaining competitive strategies in the European pharmaceutical industry |c Andrea M. Herrmann. Max Planck Institute for the Study of Societies, MPIFG |
264 | 1 | |a Köln |b MPIFG |c 2008 | |
300 | |a 31 S. |c 30 cm | ||
336 | |b txt |2 rdacontent | ||
337 | |b n |2 rdamedia | ||
338 | |b nc |2 rdacarrier | ||
490 | 1 | |a MPIFG discussion paper |v 2008,9 | |
500 | |a Literaturverz. S. 26 - 28 | ||
650 | 0 | 7 | |a Produktwettbewerb |0 (DE-588)4137898-2 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Unternehmen |0 (DE-588)4061963-1 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Pharmazeutische Industrie |0 (DE-588)4045696-1 |2 gnd |9 rswk-swf |
651 | 7 | |a Deutschland |0 (DE-588)4011882-4 |2 gnd |9 rswk-swf | |
651 | 7 | |a Großbritannien |0 (DE-588)4022153-2 |2 gnd |9 rswk-swf | |
651 | 7 | |a Italien |0 (DE-588)4027833-5 |2 gnd |9 rswk-swf | |
689 | 0 | 0 | |a Deutschland |0 (DE-588)4011882-4 |D g |
689 | 0 | 1 | |a Pharmazeutische Industrie |0 (DE-588)4045696-1 |D s |
689 | 0 | 2 | |a Unternehmen |0 (DE-588)4061963-1 |D s |
689 | 0 | 3 | |a Produktwettbewerb |0 (DE-588)4137898-2 |D s |
689 | 0 | 4 | |a Italien |0 (DE-588)4027833-5 |D g |
689 | 0 | 5 | |a Großbritannien |0 (DE-588)4022153-2 |D g |
689 | 0 | |5 DE-188 | |
810 | 2 | |a Max-Planck-Institut für Gesellschaftsforschung <Köln> |t MPIFG discussion paper |v 2008,9 |w (DE-604)BV006188088 |9 2008,9 | |
943 | 1 | |a oai:aleph.bib-bvb.de:BVB01-016879873 |
Datensatz im Suchindex
_version_ | 1820157968336814080 |
---|---|
adam_text | |
adam_txt | |
any_adam_object | |
any_adam_object_boolean | |
author | Herrmann, Andrea M. |
author_facet | Herrmann, Andrea M. |
author_role | aut |
author_sort | Herrmann, Andrea M. |
author_variant | a m h am amh |
building | Verbundindex |
bvnumber | BV023563622 |
classification_rvk | QR 525 |
ctrlnum | (OCoLC)277046457 (DE-599)DNB99070419X |
discipline | Wirtschaftswissenschaften |
discipline_str_mv | Wirtschaftswissenschaften |
format | Book |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>00000nam a2200000zcb4500</leader><controlfield tag="001">BV023563622</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20081104000000.0</controlfield><controlfield tag="007">t|</controlfield><controlfield tag="008">081021s2008 gw |||| 00||| eng d</controlfield><datafield tag="016" ind1="7" ind2=" "><subfield code="a">99070419X</subfield><subfield code="2">DE-101</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="c">geh.</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)277046457</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DNB99070419X</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="044" ind1=" " ind2=" "><subfield code="a">gw</subfield><subfield code="c">XA-DE</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-521</subfield><subfield code="a">DE-188</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">QR 525</subfield><subfield code="0">(DE-625)142044:</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">330</subfield><subfield code="2">sdnb</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Herrmann, Andrea M.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Choosing and successfully sustaining competitive strategies in the European pharmaceutical industry</subfield><subfield code="c">Andrea M. Herrmann. Max Planck Institute for the Study of Societies, MPIFG</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Köln</subfield><subfield code="b">MPIFG</subfield><subfield code="c">2008</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">31 S.</subfield><subfield code="c">30 cm</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">MPIFG discussion paper</subfield><subfield code="v">2008,9</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Literaturverz. S. 26 - 28</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Produktwettbewerb</subfield><subfield code="0">(DE-588)4137898-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Unternehmen</subfield><subfield code="0">(DE-588)4061963-1</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Pharmazeutische Industrie</subfield><subfield code="0">(DE-588)4045696-1</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="651" ind1=" " ind2="7"><subfield code="a">Deutschland</subfield><subfield code="0">(DE-588)4011882-4</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="651" ind1=" " ind2="7"><subfield code="a">Großbritannien</subfield><subfield code="0">(DE-588)4022153-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="651" ind1=" " ind2="7"><subfield code="a">Italien</subfield><subfield code="0">(DE-588)4027833-5</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Deutschland</subfield><subfield code="0">(DE-588)4011882-4</subfield><subfield code="D">g</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Pharmazeutische Industrie</subfield><subfield code="0">(DE-588)4045696-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="2"><subfield code="a">Unternehmen</subfield><subfield code="0">(DE-588)4061963-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="3"><subfield code="a">Produktwettbewerb</subfield><subfield code="0">(DE-588)4137898-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="4"><subfield code="a">Italien</subfield><subfield code="0">(DE-588)4027833-5</subfield><subfield code="D">g</subfield></datafield><datafield tag="689" ind1="0" ind2="5"><subfield code="a">Großbritannien</subfield><subfield code="0">(DE-588)4022153-2</subfield><subfield code="D">g</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-188</subfield></datafield><datafield tag="810" ind1="2" ind2=" "><subfield code="a">Max-Planck-Institut für Gesellschaftsforschung <Köln></subfield><subfield code="t">MPIFG discussion paper</subfield><subfield code="v">2008,9</subfield><subfield code="w">(DE-604)BV006188088</subfield><subfield code="9">2008,9</subfield></datafield><datafield tag="943" ind1="1" ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-016879873</subfield></datafield></record></collection> |
geographic | Deutschland (DE-588)4011882-4 gnd Großbritannien (DE-588)4022153-2 gnd Italien (DE-588)4027833-5 gnd |
geographic_facet | Deutschland Großbritannien Italien |
id | DE-604.BV023563622 |
illustrated | Not Illustrated |
index_date | 2024-07-02T22:38:22Z |
indexdate | 2025-01-02T17:11:45Z |
institution | BVB |
language | English |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-016879873 |
oclc_num | 277046457 |
open_access_boolean | |
owner | DE-521 DE-188 |
owner_facet | DE-521 DE-188 |
physical | 31 S. 30 cm |
publishDate | 2008 |
publishDateSearch | 2008 |
publishDateSort | 2008 |
publisher | MPIFG |
record_format | marc |
series2 | MPIFG discussion paper |
spelling | Herrmann, Andrea M. Verfasser aut Choosing and successfully sustaining competitive strategies in the European pharmaceutical industry Andrea M. Herrmann. Max Planck Institute for the Study of Societies, MPIFG Köln MPIFG 2008 31 S. 30 cm txt rdacontent n rdamedia nc rdacarrier MPIFG discussion paper 2008,9 Literaturverz. S. 26 - 28 Produktwettbewerb (DE-588)4137898-2 gnd rswk-swf Unternehmen (DE-588)4061963-1 gnd rswk-swf Pharmazeutische Industrie (DE-588)4045696-1 gnd rswk-swf Deutschland (DE-588)4011882-4 gnd rswk-swf Großbritannien (DE-588)4022153-2 gnd rswk-swf Italien (DE-588)4027833-5 gnd rswk-swf Deutschland (DE-588)4011882-4 g Pharmazeutische Industrie (DE-588)4045696-1 s Unternehmen (DE-588)4061963-1 s Produktwettbewerb (DE-588)4137898-2 s Italien (DE-588)4027833-5 g Großbritannien (DE-588)4022153-2 g DE-188 Max-Planck-Institut für Gesellschaftsforschung <Köln> MPIFG discussion paper 2008,9 (DE-604)BV006188088 2008,9 |
spellingShingle | Herrmann, Andrea M. Choosing and successfully sustaining competitive strategies in the European pharmaceutical industry Produktwettbewerb (DE-588)4137898-2 gnd Unternehmen (DE-588)4061963-1 gnd Pharmazeutische Industrie (DE-588)4045696-1 gnd |
subject_GND | (DE-588)4137898-2 (DE-588)4061963-1 (DE-588)4045696-1 (DE-588)4011882-4 (DE-588)4022153-2 (DE-588)4027833-5 |
title | Choosing and successfully sustaining competitive strategies in the European pharmaceutical industry |
title_auth | Choosing and successfully sustaining competitive strategies in the European pharmaceutical industry |
title_exact_search | Choosing and successfully sustaining competitive strategies in the European pharmaceutical industry |
title_exact_search_txtP | Choosing and successfully sustaining competitive strategies in the European pharmaceutical industry |
title_full | Choosing and successfully sustaining competitive strategies in the European pharmaceutical industry Andrea M. Herrmann. Max Planck Institute for the Study of Societies, MPIFG |
title_fullStr | Choosing and successfully sustaining competitive strategies in the European pharmaceutical industry Andrea M. Herrmann. Max Planck Institute for the Study of Societies, MPIFG |
title_full_unstemmed | Choosing and successfully sustaining competitive strategies in the European pharmaceutical industry Andrea M. Herrmann. Max Planck Institute for the Study of Societies, MPIFG |
title_short | Choosing and successfully sustaining competitive strategies in the European pharmaceutical industry |
title_sort | choosing and successfully sustaining competitive strategies in the european pharmaceutical industry |
topic | Produktwettbewerb (DE-588)4137898-2 gnd Unternehmen (DE-588)4061963-1 gnd Pharmazeutische Industrie (DE-588)4045696-1 gnd |
topic_facet | Produktwettbewerb Unternehmen Pharmazeutische Industrie Deutschland Großbritannien Italien |
volume_link | (DE-604)BV006188088 |
work_keys_str_mv | AT herrmannandream choosingandsuccessfullysustainingcompetitivestrategiesintheeuropeanpharmaceuticalindustry |